
Lessons from Recent FDA Warning Letters in Pharmaceutical Manufacturing
Analyzing regulatory enforcement actions provides a roadmap for maintaining a compliant manufacturing environment. This guide explores the most critical FDA Warning Letters Lessons from recent years, focusing on data integrity failures, inadequate CAPA systems, and poor management oversight. Learn how to transform these industry failures into a robust readiness strategy that safeguards your facility from similar enforcement actions.










